DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: TREATMENTS
       *****************************************************
       #Post#: 4783--------------------------------------------------
       (AAN abst.) [Early high-efficacy DMT vs. early low-efficacy DMT 
       in a cohort of PwMS]
       By: agate Date: April 24, 2025, 1:03 am
       ---------------------------------------------------------
       These researchers took a group of people with MS between the
       ages of 12 and 50 and, testing  early initiation of
       disease-modifying therapy, treated some with high-efficacy DMTs
       and some with low-efficacy DMTs. The aim was to find out whether
       the high-efficacy DMTs might work better than the low-efficacy
       DMTs at delaying progression and disability accumulation. They
       found that there was no difference.
       Presented at the AAN conference this month--"Risk of progression
       independent of relapse activity [PIRA] and disability
       accumulation in a real-world cohort of multiple sclerosis
       patients initiated on high-efficacy vs. low-efficacy
       disease-modifying therapy":
  HTML https://index.mirasmart.com/AAN2025/PDFfiles/AAN2025-002449.html
       *****************************************************